GL1X · GenesisL1 explorer

MolNFT v1 · #88330 · protein

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

4CRF · Coagulation factor xia light chain: “Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design”. X-ray diffraction, 3 ligands (R9B, SO4, CL), 2 pockets (best druggability 0.46). MolNFT v1…

PDB
4CRF
Type
protein
Length
238 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Coagulation factor xia light chain
UniProt
P03951
Ligands
R9B, SO4, CL
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACoagulation factor xia light chainprotein23815% helix, 34% strandP03951

Ligands and binding sites

  • R9B · N-[(1S)-1-benzyl-2-[(6-chloro-2-oxo-1H-quinolin-4-yl)methylamino]-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carbo · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A
  • CL · Chloride ion · ion · chains A
  • GOL · Glycerol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11430.460.7725GOL, R9B
21160.450.7821empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 4CRF · Creating novel F1 inhibitors through fragment based lead generation and structure aided… · the same entry in another collection · chain A against A, TM-score 1.00
  • P03951 · AlphaFold monomer V2.0 prediction for coagulation factor XI (P03951) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.